A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies

计划入组 58 人 · 首次发布于 2013 年 12 月 17 日

A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

计划入组 113 人 · 首次发布于 2015 年 9 月 14 日

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

计划入组 77 人 · 首次发布于 2014 年 1 月 15 日

Hematopoïetic StemCell Transplantation(Pk Med)

PKM-011

PK-101

Med Resources, Inc.

United States

BeBetter Med Inc.

China

Orano Med LLC

United States

PK MED Strengthens Governance with Gene Therapy Pioneers Ahead of Phase 2 Gout Trial

Bioanalysis Emerges as Critical Foundation for Precision Medicine Development

FDA Expands Indications for MED-EL Cochlear Implants, Approves Hearing Preservation Claims